JPWO2023190812A1 - - Google Patents

Info

Publication number
JPWO2023190812A1
JPWO2023190812A1 JP2023542946A JP2023542946A JPWO2023190812A1 JP WO2023190812 A1 JPWO2023190812 A1 JP WO2023190812A1 JP 2023542946 A JP2023542946 A JP 2023542946A JP 2023542946 A JP2023542946 A JP 2023542946A JP WO2023190812 A1 JPWO2023190812 A1 JP WO2023190812A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023542946A
Other languages
Japanese (ja)
Other versions
JP7417010B1 (ja
JPWO2023190812A5 (https=
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023190812A1 publication Critical patent/JPWO2023190812A1/ja
Application granted granted Critical
Publication of JP7417010B1 publication Critical patent/JP7417010B1/ja
Publication of JPWO2023190812A5 publication Critical patent/JPWO2023190812A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2023542946A 2022-03-31 2023-03-30 癌免疫増強用のvipr2アンタゴニストペプチド Active JP7417010B1 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022057810 2022-03-31
JP2022057810 2022-03-31
PCT/JP2023/013061 WO2023190812A1 (ja) 2022-03-31 2023-03-30 癌免疫増強用のvipr2アンタゴニストペプチド

Publications (3)

Publication Number Publication Date
JPWO2023190812A1 true JPWO2023190812A1 (https=) 2023-10-05
JP7417010B1 JP7417010B1 (ja) 2024-01-17
JPWO2023190812A5 JPWO2023190812A5 (https=) 2024-03-08

Family

ID=88202732

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023542946A Active JP7417010B1 (ja) 2022-03-31 2023-03-30 癌免疫増強用のvipr2アンタゴニストペプチド

Country Status (2)

Country Link
JP (1) JP7417010B1 (https=)
WO (1) WO2023190812A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4137502A4 (en) * 2020-03-30 2024-02-28 Ichimaru Pharcos Co., Ltd. Vipr2 antagonist peptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4137502A4 (en) * 2020-03-30 2024-02-28 Ichimaru Pharcos Co., Ltd. Vipr2 antagonist peptide

Also Published As

Publication number Publication date
JP7417010B1 (ja) 2024-01-17
WO2023190812A9 (ja) 2023-11-23
WO2023190812A1 (ja) 2023-10-05

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
JPWO2023162456A1 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
CN307045880S (https=)
BY13143U (https=)
BY13169U (https=)
CN307045955S (https=)
CN307046001S (https=)
CN307046266S (https=)
CN307047554S (https=)
CN307048409S (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230714

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230714

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20230714

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230714

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230926

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231023

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231031

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231219

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240104

R150 Certificate of patent or registration of utility model

Ref document number: 7417010

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150